Sexual HealthWell StudiedPrescription

PT-141

Also known as: Bremelanotide, Vyleesi

PT-141 (bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist, specifically targeting the MC4R receptor in the central nervous system. Unlike phosphodiesterase inhibitors such as sildenafil, PT-141 works through a distinct neurological pathway to enhance sexual desire and arousal. It was FDA-approved in 2019 under the brand name Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in perimenopausal women.

Research Score8/10

Extensive clinical evidence

Safety Score7/10

Generally safe with some considerations

How It Works

PT-141 activates melanocortin-4 receptors (MC4R) in the brain, directly stimulating neural pathways involved in sexual arousal and desire.

Key Benefits

  • Increases sexual desire through central nervous system pathways
  • FDA-approved for hypoactive sexual desire disorder in women
  • Works independently of vascular mechanisms
  • On-demand dosing approximately 45 minutes before activity
  • May benefit both men and women with desire-related dysfunction

Who May Benefit

  • Women with hypoactive sexual desire disorder
  • Men with ED not responding to PDE5 inhibitors
  • Those addressing both desire and arousal
  • People seeking alternatives to traditional ED medications

Dosage & Administration

Typical Dosage
Administered at least 45 minutes before anticipated sexual activity, no more than once daily
Cycle Length
On-demand use; no more than one dose per 24 hours or 8 doses per month
Administration Routes
subcutaneousnasal

Expected Timeline

Effects in 30-60 minutes lasting 24-72 hours. Used as-needed.

Safety Information

Possible Side Effects

Nausea (most common, approximately 40%)Facial flushingHeadacheInjection site reactionsTransient increase in blood pressureSkin hyperpigmentation with repeated use

Contraindications

Uncontrolled hypertensionCardiovascular diseasePregnancy or breastfeedingKnown hypersensitivity to bremelanotideConcurrent use with naltrexone
Dr. Patrick Taylor, MD

Dr. Taylor's 2 Cents

“PT-141 is unique because it works on desire, not just mechanics. It's the only FDA-approved treatment for hypoactive sexual desire disorder, and it works through a completely different mechanism than Viagra or Cialis. I use it for both men and women. It's an on-demand medication.”

Discuss with Dr. Taylor →

Frequently Asked Questions

How is PT-141 different from Viagra?
Works in the brain on melanocortin receptors for desire and arousal, not just blood flow.
Is PT-141 FDA approved?
Yes, for premenopausal women with HSDD (Vyleesi). Off-label use in men is common.
How is it administered?
Subcutaneous injection about 45 minutes before activity, as-needed.
What are the side effects?
Nausea (about 40%), flushing, headache. Usually mild and temporary.
Does it work for both sexes?
Yes, effective in both. Only FDA-approved treatment for female sexual desire disorder.

Published Research

1

An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist

Diamond LE, Earle DC, Heiman JR, Rosen RC, Perelman MA, Harning R · Journal of Sexual Medicine (2006)

Key Finding: Significantly more women reported moderate or high sexual desire following bremelanotide vs placebo, with greater satisfaction in arousal among those who attempted intercourse.

PubMed →DOI →
2

Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction

Diamond LE, Earle DC, Rosen RC, Willett MS, Molinoff PB · International Journal of Impotence Research (2004)

Key Finding: Intranasal PT-141 induced a statistically significant erectile response vs placebo at doses above 7 mg, with onset in approximately 30 minutes and no clinically significant adverse effects.

PubMed →DOI →

Protocols Featuring PT-141

Men's Sexual Health Protocol
Libido and performance support
Women's Sexual Wellness Protocol
Desire and hormonal balance

Related Reading

A Beginner's Guide to Peptide Therapy
Everything you need to know about therapeutic peptides, how they work, and what to expect when starting peptide therapy.

Want personalized guidance?

Consult with Dr. Patrick Taylor for a comprehensive evaluation and personalized protocol.

Book a Consultation

Medical Disclaimer: This information is for educational purposes only and is not medical advice. Consult a healthcare provider before starting any peptide protocol.